Celgene Corporation (CELG)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
107.18+0.87 (+0.82%)
As of 1:06 PM EDT. Market open.
People also watch:
GILDBIIBREGNAMGNALXN
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open106.51
Prev Close106.31
Bid107.00 x 200
Ask107.03 x 100
Day's Range105.69 - 107.46
52wk Range93.05 - 128.39
1y Target EstN/A
Market Cap83.08B
P/E Ratio (ttm)45.30
Beta1.47
Volume1,486,470
Avg Vol (3m)4,233,382
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Barrons.com2 hours ago

    Amgen: The Blame Game

    This morning, Amgen (AMGN) reported that its cancer drug Kyprolis failed to do what it hoped it would in a late-stage trial. RBC's Michael Yee and Judy Liu wonder if the design of the trial was to blame: Amgen announced the Clarion study (head to head versus Velcade) did not meet stat sig for progression free survival although survival did show a solid trend (Hr=1.21). This is a surprise since the prior Endeavor second line study was a very big success and today's result in first line may be due to lack of sufficient powering in our view, given strong trend in survival and deeper responses with Kyprolis should better especially earlier.

  • Celgene Corp. – Value Analysis (NASDAQ:CELG) : September 27, 2016
    Capital Cube2 hours ago

    Celgene Corp. – Value Analysis (NASDAQ:CELG) : September 27, 2016

    Categories: Fundamental Analysis Yahoo Finance Click here to see latest analysis Capitalcube gives Celgene Corp. a score of 69. Our analysis is based on comparing Celgene Corp. with the following peers – Amgen Inc., Gilead Sciences, Inc., Biogen Inc., OncoMed Pharmaceuticals, Inc., Eli Lilly and Company, Johnson & Johnson, Alexion Pharmaceuticals, Inc., Illumina, Inc., Epizyme, Inc. and ARIAD Pharmaceuticals, Inc. ... Read more (Read more...)

  • Kiplinger4 hours ago

    6 Blue-Chip Stocks to Buy and Hold for the Next 10 Years

    Thinkstock When it comes to stocks, we like playing the long game: picking solid companies, sticking with them through tough times and hanging on for years, even a decade or more. Investing for the long ...